Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Cancer Stage Iv”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01164228
What this trial is testing

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
ECOG-ACRIN Cancer Research Group 87
Testing effectiveness (Phase 2)Study completedNCT00471536
What this trial is testing

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

Who this might be right for
Distal Urethral CancerProximal Urethral CancerRecurrent Bladder Cancer+5 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00006111
What this trial is testing

Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
UNICANCER 53
Testing effectiveness (Phase 2)Ended earlyNCT00323791
What this trial is testing

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Medicine and Dentistry of New Jersey 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT01684397
What this trial is testing

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer
Roswell Park Cancer Institute 51
Large-scale testing (Phase 3)Active Not RecruitingNCT06500455
What this trial is testing

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Digestive System Carcinoma+7 more
NRG Oncology 274
Testing effectiveness (Phase 2)UnknownNCT00002589
What this trial is testing

Lymphocyte Therapy in Treating Patients With Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT01688973
What this trial is testing

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00019539
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Stage IV Renal Cell CancerRecurrent Renal Cell Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT02526511
What this trial is testing

Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors

Who this might be right for
Stage I Renal Cell CancerStage II Renal Cell CancerStage III Renal Cell Cancer+1 more
Rutgers, The State University of New Jersey 75
Early research (Phase 1)Study completedNCT00623064
What this trial is testing

Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
European Organisation for Research and Treatment of Cancer - EORTC 18
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00354250
What this trial is testing

Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Early research (Phase 1)Study completedNCT00020540
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Testing effectiveness (Phase 2)Study completedNCT00792025
What this trial is testing

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Institut Curie 80
Very early researchActive Not RecruitingNCT02812420
What this trial is testing

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

Who this might be right for
HydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT01141569
What this trial is testing

RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 12
Next Page